Internet-based self-help interventions significantly improve IBS symptom severity and quality of life across diverse global populations in this systematic review

This systematic review and meta-analysis evaluated the efficacy of internet-based self-help interventions for individuals suffering from irritable bowel syndrome. The study pooled data from 2,289 participants recruited across seven different countries, providing a broad perspective on the real-world applicability of digital mental health tools for functional gastrointestinal disorders. The primary objective was to determine whether these interventions could effectively reduce the severity of IBS symptoms compared to standard control groups. Secondary outcomes included assessments of quality of life, visceral sensitivity, and psychological symptoms such as depression and anxiety.

The analysis revealed that internet-based self-help interventions produced a statistically significant improvement in IBS symptom severity. The standardized mean difference was -0.52, indicating a moderate effect size that favored the intervention group. This reduction in symptom burden suggests that digital platforms can be a viable adjunct to traditional management strategies. Furthermore, the interventions led to a statistically significant enhancement in quality of life, with a standardized mean difference of 0.57. This dual benefit addresses both the physical discomfort and the psychosocial impact often associated with chronic IBS.

Visceral sensitivity, a key feature of IBS pathophysiology, also showed statistically significant improvement following the intervention. The effect size for this outcome was -0.55, reinforcing the potential of these digital tools to modulate gut-brain axis dysfunction. However, the analysis of anxiety symptoms did not demonstrate a statistically significant improvement. The standardized mean difference was minimal at -0.03, and the confidence intervals crossed zero, suggesting that while these interventions help with core IBS symptoms, they may not directly target anxiety disorders without additional specific therapeutic components.

Depressive symptoms, conversely, showed a statistically significant improvement with a standardized mean difference of -0.14. Although the effect size was smaller than that observed for symptom severity, the direction of the effect was consistent with clinical benefit. This finding is particularly relevant given the high comorbidity between IBS and mood disorders. The lack of reported adverse events, serious adverse events, or discontinuations suggests a favorable safety profile for these low-intensity digital interventions.

Despite the positive outcomes, the study acknowledges several limitations. The evidence certainty was rated as moderate to very low for all outcomes due to high heterogeneity among the included studies and a moderate risk of bias. The wide prediction intervals further indicate that the true effect in a specific setting could vary considerably from the average effect observed in the meta-analysis. These factors necessitate cautious interpretation of the results and suggest that clinicians should tailor expectations based on local context.

The practice relevance of these findings is substantial, particularly for primary care providers and telemedicine platforms. In resource-limited regions where access to specialized gastroenterologists or mental health professionals may be scarce, internet-based self-help offers a scalable solution. These tools can empower patients to manage their condition independently while maintaining a connection with their healthcare team. Future implementations should consider the heterogeneity identified in the study to ensure that digital interventions are adapted to specific patient populations and cultural contexts.